StockWatch
·

TRANSCHEM LTD.-$ Q2 FY27 Results

TRANSCHEMQ2 FY27 Results
Filing
Result:Steady· Market: Flat#One-off gain#Base effect
MetricValue (₹ Cr)
Revenue0.93
Total Income5.07
Expenditure2.21
PBT2.86
Net Profit2.05
OPM—
NPM40.47%
EPS1.68
View full financials

Core pharma revenue is negligible in both periods (~₹0.9 Cr) and the 202% PAT growth is driven almost entirely by other income (₹4.14 Cr) off a tiny prior-year base, not operating business growth.

Informational and educational content only. Not investment advice.